51 F
New York
Tuesday, April 20, 2021

AstraZeneca [NYSE: AZN] Concludes COVID-19 Vaccine Supply Deal In Europe

Must read

IAA [NYSE: IAA] Announces Expansion of Delivery Services in the UK

IAA, Inc. disclosed that its UK-based business unit has decided to expand its vehicle delivery services for its buyers. This expansion decision has...

ICON [NASDAQ: ICLR] Secures Multiple Categories in 2021 CRO Leadership Awards

ICON Public Limited Company has disclosed that it has won multiple categories in the annual CRO Leadership Awards. This is another greatest achievement...

Equinox Announces Sale of Pilar Gold Mine

Equinox Gold Corp. revealed Monday that it has decided to sell its Pilar Gold Mine in Brazil to Pilar Gold Inc. The firm...

OpGen [NASDAQ: OPGN] Announces Strategic Collaboration New York State Department of Health

OpGen, Inc. revealed that it has entered into a strategic collaboration deal with the New York State Department of Health. The focus of...

AstraZeneca PLC [NYSE: AZN] disclosed Friday it has closed the supply deal of 400 million doses of the AZD1222 COVID-19 vaccine with European Commission.

This new deal will allow European member states to access the vaccine in an equitable manner at no profit amid pandemic.

This new supply deal between AZN & European Commission also gives rights to European member states to redirect doses to other European countries.

[candlestick-chart id=”2″]

Shares of AstraZeneca exhibited a change of 1.66% at a closing price of $55.80 during the trading session of Thursday. It has day low range $55.69 and a day high range of $56.43.

In the past 52-weeks of trading, AstraZeneca shares fluctuated between the low of $36.15 and a high of $64.94. It has moved up 54.36% from its 52-weeks low and moved down -14.07% from its 52-weeks high.

If we turn our focus on its profitability, its return on assets (ROA) is 3.60%, return on investment (ROI) is 8.30%, and ROE is 17.80%.

Furthermore, it has a Gross Margin of 80.30%, a Profit Margin of 8.40%, and an Operating Margin of 14.90%.

Continuing to look at its liquidity, its current ratio is 0.80. Likewise, its quick ratio is 0.60. AstraZeneca has a total debt to equity ratio of 1.61 and a long term debt to equity ratio of 1.28.

AZD1222 has shown a positive result in July 2020. AZD1222 has generated robust immune responses against SARS-CoV-19. The clinical trial of AZD-1222 is ongoing around the globe.

Furthermore, its trial entered into phase I/II in South Africa and has started phase II/III in Brazil and the UK.

AZD1222 was co-invented by the University of Oxford and its spin-out company, Vaccitech. AZD1222 uses a replication-deficient chimpanzee viral vector.

It based on a weakened version of a common cold virus that causes infections in chimpanzees. Additionally, it also contains the genetic material of the SARS-CoV-2 virus spike protein.

More articles

Latest article

Why Mer Telemanagement [NASDAQ: MTSL] Skyrocketed on Friday?

Shares of Mer Telemanagement Solutions Ltd skyrocketed during the trading session of Friday. The strong performance of the firm has indicated the positive...

Largo Resources Gets Approval for Listing on Nasdaq Stock Exchange

Largo Resources disclosed that it has finally obtained authorization from Nasdaq Stock Market LLC. As per the approval, the firm will now eligible to...

Aurora Mobile [NASDAQ: JG] Inks Agreement with Wanda Film

Aurora Mobile Limited disclosed Thursday that it has inked an agreement with Wanda Film Holding Co Ltd. Since its inception, Aurora Mobile has...

Brady [NYSE: BRC] Commence Tender Offer to Buy Nordic ID Oyj

Brady Corporation has inked an agreement with Nordic ID for its acquisition. The firm has commenced the tender offering to buy all the...

Cinedigm [NASDAQ: CIDM] Achieve Record Subscription and Ad-Supported User Growth Milestones

Shares of Cinedigm Corp. skyrocketed 19.30% after the firm reported the update about the subscription. The firm has achieved the best ever achievement...

Aurora Mobile [NASDAQ: JG] Signs Partnership Agreement with Yivi

Aurora Mobile Limited revealed that it has inked a collaboration deal with Hangzhou Yivi Intelligent Technology Co., LTD. (Yivi). Yivi and Aurora both...

Total [NYSE: TOT] Join Forces with Siemens Energy to Reduce LNG Related Emissions

Total SE has joined forces with Siemens Energy to explore the solution for the reduction of CO2 emissions. The firms have inked a...

Kaixin [NASDAQ: KXIN] Signs Cooperation Agreement with Jingdong

Kaixin Auto Holdings declared Monday that it has inked a deal with Jingdong Century Trade Limited. The agreement is the collaboration agreement between...